AMERICAN BIO MEDICA CORPORATION Financials American Bio Medica Corporation
Equities
ABMC
US0246001087
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | -.--% |
|
-.--% | -.--% |
| 2023 | American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2023 | American Bio Medica Corporation Auditor Raises 'Going Concern' Doubt | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2.93 | 2.082 | 2.288 | 4.901 | 1.785 | 0.2645 |
| Enterprise Value (EV) 1 | 4.218 | 3.504 | 3.853 | 6.681 | 3.251 | 2.471 |
| P/E ratio | -5.36 x | -2.01 x | -3.34 x | -5.81 x | -3.46 x | -0.19 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.6 x | 0.54 x | 0.63 x | 1.18 x | 0.8 x | 0.29 x |
| EV / Revenue | 0.86 x | 0.9 x | 1.05 x | 1.61 x | 1.47 x | 2.71 x |
| EV / EBITDA | -18.3 x | -5.14 x | -7.52 x | -12.3 x | -2.93 x | -1.93 x |
| EV / FCF | 21.3 x | 32.7 x | 23.2 x | -36.4 x | -3.28 x | -7.95 x |
| FCF Yield | 4.69% | 3.06% | 4.3% | -2.75% | -30.5% | -12.6% |
| Price to Book | 4.78 x | -15.2 x | -2.9 x | -3.9 x | -1.89 x | -0.11 x |
| Nbr of stocks (in thousands) | 29,297 | 30,279 | 32,681 | 37,703 | 47,598 | 48,098 |
| Reference price 2 | 0.1000 | 0.0688 | 0.0700 | 0.1300 | 0.0375 | 0.005500 |
| Announcement Date | 12/04/18 | 16/04/19 | 26/06/20 | 15/04/21 | 15/04/22 | 21/03/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4.914 | 3.872 | 3.655 | 4.147 | 2.218 | 0.913 |
| EBITDA 1 | -0.231 | -0.681 | -0.512 | -0.542 | -1.111 | -1.281 |
| EBIT 1 | -0.311 | -0.762 | -0.593 | -0.621 | -1.179 | -1.332 |
| Operating Margin | -6.33% | -19.68% | -16.22% | -14.97% | -53.16% | -145.89% |
| Earnings before Tax (EBT) 1 | -0.545 | -1.026 | -0.686 | -0.794 | -0.461 | -1.408 |
| Net income 1 | -0.545 | -1.028 | -0.681 | -0.796 | -0.463 | -1.41 |
| Net margin | -11.09% | -26.55% | -18.63% | -19.19% | -20.87% | -154.44% |
| EPS 2 | -0.0187 | -0.0341 | -0.0209 | -0.0224 | -0.0108 | -0.0294 |
| Free Cash Flow 1 | 0.1976 | 0.1072 | 0.1658 | -0.1835 | -0.9911 | -0.3108 |
| FCF margin | 4.02% | 2.77% | 4.53% | -4.42% | -44.69% | -34.04% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 12/04/18 | 16/04/19 | 26/06/20 | 15/04/21 | 15/04/22 | 21/03/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.29 | 1.42 | 1.57 | 1.78 | 1.47 | 2.21 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -5.576 x | -2.088 x | -3.057 x | -3.284 x | -1.32 x | -1.722 x |
| Free Cash Flow 1 | 0.2 | 0.11 | 0.17 | -0.18 | -0.99 | -0.31 |
| ROE (net income / shareholders' equity) | -66.1% | -431% | 146% | 77.8% | 42.1% | 85.9% |
| ROA (Net income/ Total Assets) | -6.21% | -17.8% | -16.3% | -19.4% | -38.7% | -52.8% |
| Assets 1 | 8.779 | 5.791 | 4.183 | 4.106 | 1.197 | 2.669 |
| Book Value Per Share 2 | 0.0200 | -0 | -0.0200 | -0.0300 | -0.0200 | -0.0500 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capex 1 | 0.04 | - | - | 0 | - | - |
| Capex / Sales | 0.9% | - | - | 0.1% | - | - |
| Announcement Date | 12/04/18 | 16/04/19 | 26/06/20 | 15/04/21 | 15/04/22 | 21/03/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 4.81K | |
| -4.47% | 12.39B | |
| -0.60% | 8.43B | |
| +6.52% | 5.77B | |
| +32.52% | 5.76B | |
| -10.21% | 4.1B | |
| +10.62% | 2.66B | |
| -61.40% | 2.66B | |
| -7.81% | 2.39B | |
| +16.92% | 2.02B |
- Stock Market
- Equities
- ABMC Stock
- Financials American Bio Medica Corporation